PT1293210E - Dispositivo e metodo anticoncepcional hormonal - Google Patents

Dispositivo e metodo anticoncepcional hormonal

Info

Publication number
PT1293210E
PT1293210E PT01201945T PT01201945T PT1293210E PT 1293210 E PT1293210 E PT 1293210E PT 01201945 T PT01201945 T PT 01201945T PT 01201945 T PT01201945 T PT 01201945T PT 1293210 E PT1293210 E PT 1293210E
Authority
PT
Portugal
Prior art keywords
hormone units
estrogen
daily
phase
units
Prior art date
Application number
PT01201945T
Other languages
English (en)
Inventor
Agatha Antonia Magdalena Beek
Herman Jan Tijmen Coel Bennink
Original Assignee
Pantarhei Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv
Publication of PT1293210E publication Critical patent/PT1293210E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
PT01201945T 2001-05-23 2001-05-23 Dispositivo e metodo anticoncepcional hormonal PT1293210E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01201945A EP1293210B1 (en) 2001-05-23 2001-05-23 Means and method for hormonal contraception

Publications (1)

Publication Number Publication Date
PT1293210E true PT1293210E (pt) 2004-04-30

Family

ID=8180360

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01201945T PT1293210E (pt) 2001-05-23 2001-05-23 Dispositivo e metodo anticoncepcional hormonal

Country Status (10)

Country Link
US (1) US20040242550A1 (pt)
EP (1) EP1293210B1 (pt)
AT (1) ATE254465T1 (pt)
CA (1) CA2448280A1 (pt)
DE (1) DE60101276T2 (pt)
DK (1) DK1293210T3 (pt)
ES (1) ES2208518T3 (pt)
PT (1) PT1293210E (pt)
TR (1) TR200400183T4 (pt)
WO (1) WO2002094281A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1556058T3 (da) 2002-10-23 2008-03-03 Pantarhei Bioscience Bv Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
DK1462107T3 (da) * 2003-03-28 2008-11-03 Pantarhei Bioscience Bv Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde
DE102004026671A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102004026670A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
WO2006036055A2 (en) * 2004-09-27 2006-04-06 Pantarhei Bioscience B. V. Method of female contraception and kit for use in such method
DE102005056527A1 (de) * 2005-11-25 2007-07-12 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination
US20080021003A1 (en) * 2006-06-13 2008-01-24 Vladimir Hanes Extended step-down estrogen regimen
CA2988498C (en) 2015-06-18 2022-02-08 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
RS62844B1 (sr) 2015-06-18 2022-02-28 Estetra Srl Orodisperzibilna dozna jedinica koja sadrži komponentu estetrola
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN109820859A (zh) * 2019-04-09 2019-05-31 上海市计划生育科学研究所 醋酸诺美孕酮在制备预防或治疗呕吐或改善恶病质的药物中的应用
WO2023135506A1 (en) * 2022-01-13 2023-07-20 Arena Pharmaceuticals, Inc. Etrasimod for use in treating s1p1 receptor-associated disorders in combination with hormone treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
DE4224534A1 (de) * 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente

Also Published As

Publication number Publication date
DE60101276T2 (de) 2004-04-22
EP1293210A1 (en) 2003-03-19
EP1293210B1 (en) 2003-11-19
CA2448280A1 (en) 2002-11-28
DE60101276D1 (de) 2003-12-24
ATE254465T1 (de) 2003-12-15
WO2002094281A1 (en) 2002-11-28
US20040242550A1 (en) 2004-12-02
ES2208518T3 (es) 2004-06-16
TR200400183T4 (tr) 2004-02-23
DK1293210T3 (da) 2004-03-15

Similar Documents

Publication Publication Date Title
PT1293210E (pt) Dispositivo e metodo anticoncepcional hormonal
ATE241361T1 (de) Mittel zur hormonalen kontrazeption
HUP0300335A2 (hu) 8béta-hidrokarbil-szubsztituált ösztratriének mint szelektív hatású ösztrogének, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
RS20060348A (en) Extended use combination comprising estrogens and progestins
TR199802705T2 (xx) Progestojen-anti-progestojen k�r�
BG111090A (bg) Контрацептивен процес и форми на приложение за същия
DK0491438T3 (da) Svangerskabsforebyggende behandling
WO2003039553B1 (en) Compositions for treatment of postmenopausal female sexual dysfunction
NZ234051A (en) Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity
NO982902L (no) FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen
EA201201221A1 (ru) Фармацевтическая композиция для контрацепции и заместительной гормональной терапии
HRP20030387A2 (en) Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases
MXPA02004084A (es) Nueva composicion hormonal y su utilizacion.
BR0206367A (pt) Uso de antigestágenos para inibir o amadurecimento endométrico acelerado durante o tratamento da infertilidade
UY26965A1 (es) Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
BR0010070A (pt) Uso de org 33245, kit contraceptivo, meio combinado para a dosagem de um progestogênio e um antiprogestogênio, e, métodos de contracepção, e de tratamento de sangramento uterino irregular ou de ruptura em uma fêmea utilizando uma preparação somente de progestogênio
NO974255L (no) Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner
TW200733955A (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
RU99124298A (ru) Способ коррекции гемокоагуляционных нарушений при гестозе беременных